362 EFFECT OF TIME OF REMOVAL OF A PROGESTERONE RELEASING DEVICE AND GnRH TREATMENT ON THE INTERVAL TO AND DISTRIBUTION OF OVULATIONS IN SUPERSTIMULATED BEEF COWS

Abstract

An experiment was designed to evaluate the effect of the time of removal of an intravaginal progesterone (P4) releasing device and GnRH treatment on the interval to and the distribution of ovulations in beef cows superstimulated with Folltropin-V (Bioniche Animal Health, Belleville, Ontario, Canada). Red Angus donors (22 cows and 12 heifers) with a body condition score between 2.5 to 3.5 out of 5 were blocked by parity and randomly assigned to one of four treatment groups in a 2 × 2 factorial design. On Day 0, all donors received an i.m. DIB vaginal device (Syntex, Argentina) plus 2.5 mg estradiol-17β and 50 mg P4 (Laboritorio Rio de Janeiro, Argentina). Superstimulatory treatments were initiated on Day 4, with a total dose of 320 mg (cows) or 200 mg (heifers) NIH-FSH-P1 (Folltropin-V; Bioniche Animal Health, Inc., Belleville, Ontario, Canada) in twice daily i.m. injections over 4 days. All cows received PGF treatment (150 μD(+)cloprostenol: Ciclase; Syntex) in the morning and afternoon of Day 6 and were randomly divided to have DIB devices removed at the time of the second PGF treatment (Day 6.5) or 12 h later (Day 7). On Day 8, donors were further subdivided to receive GnRH (0.050 mg Lecirelina, Gonasyn; Syntex) or no further treatment, and all cows were fixed-time AI either 60 and 72 h after the first PGF injection (0 h). All cows and heifers were examined by ultrasonography every 8 h for a period of 120 h commencing at the time of DIB removal, to determine the time and distribution of ovulations. For each cow, mean time of ovulation was used for the statistical analysis. The distributions of ovulations were compared among groups by Levene's test, and then by ANOVA (equal variances) or Friedman two-way non-parametric ANOVA (unequal variances). No significant differences were detected between cows and heifers (P > 0.13) for the parameters evaluated, and data were combined. There was no effect (P > 0.22) of treatment on the number of ovulations (GnRH: 12.6 ± 1.6 vs. no GnRH: 15.1 ± 1.1 and Day 6.5: 13.7 ± 1.3 vs. Day 7: 14.3 ± 1.5), or numbers of transferable embryos (GnRH: 5.1 ± 1.1 vs. no GnRH: 3.1 ± 0.8 and Day 6.5: 3.5 ± 0.8 vs. Day 7: 4.81 ± 0.1). However, there was a significant effect of GnRH treatment and a GnRH-by-time-of-DIB-removal interaction on the distribution of ovulations (P < 0.05; Table 1). The administration of GnRH in a superstimulatory protocol using P4 releasing devices results in earlier and more synchronous ovulations than when GnRH is not used.

Table 1. Distribution of ovulations (hours after the first PGF) in superstimulated Red Angus donors treated with progesterone-releasing devices (DIB) for 6.5 or 7 days with and without GnRH treatment on Day 8